Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer
Clinical trial NCT00006370 · COMPLETED
Trial details
- NCT number
- NCT00006370
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-07-01
- Primary completion
- 2004-06-01
- Enrollment
- 275
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.